AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Dimitroulakos, J Ye, LY Benzaquen, M Moore, MJ Kamel-Reid, S Freedman, MH Yeger, H Penn, LZ
Citation: J. Dimitroulakos et al., Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: Therapeutic implications, CLIN CANC R, 7(1), 2001, pp. 158-167

Authors: Yeger, H Pan, J Fu, XW Bear, C Cutz, E
Citation: H. Yeger et al., Expression of CFTR and Cl- conductances in cells of pulmonary neuroepithelial bodies, AM J P-LUNG, 281(3), 2001, pp. L713-L721

Authors: Kocialkowski, S Yeger, H Kingdom, J Perbal, B Schofield, PN
Citation: S. Kocialkowski et al., Expression of the human NOV gene in first trimester fetal tissues, ANAT EMBRYO, 203(6), 2001, pp. 417-427

Authors: Kazemian, P Stephenson, R Yeger, H Cutz, E
Citation: P. Kazemian et al., Respiratory control in neonatal mice with NADPH oxidase deficiency, RESP PHYSL, 126(2), 2001, pp. 89-101

Authors: Geva, E Yaron, Y Shomrat, R Ben-Yehuda, A Zabari, S Peretz, H Naiman, T Yeger, H Orr-Urtreger, A
Citation: E. Geva et al., The risk of Fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known Fragile X families, GENET TEST, 4(3), 2000, pp. 289-292

Authors: Gyomorey, K Yeger, H Ackerley, C Garami, E Bear, CE
Citation: K. Gyomorey et al., Expression of the chloride channel ClC-2 in the murine small intestine epithelium, AM J P-CELL, 279(6), 2000, pp. C1787-C1794

Authors: Watzka, SBC Lucien, J Shimada, M Edwards, V Yeger, H Hannigan, G Coles, JG
Citation: Sbc. Watzka et al., Selection of viable cardiomyocytes for cell transplantation using three-dimensional tissue culture, TRANSPLANT, 70(9), 2000, pp. 1310-1317

Authors: Horowitz, M Pasmanik-Chor, M Borochowitz, Z Falik-Zaccai, T Heldmann, K Carmi, R Parvari, R Beit-Or, H Goldman, B Peleg, L Levy-Lahad, E Renbaum, P Legum, S Shomrat, R Yeger, H Benbenisti, D Navon, R Dror, V Shohat, M Magal, N Navot, N Eyal, N
Citation: M. Horowitz et al., Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewishpopulation (vol 12, pg 240, 1998), HUM MUTAT, 13(3), 1999, pp. 255-255

Authors: Macaulay, RJB Wang, W Dimitroulakos, J Becker, LE Yeger, H
Citation: Rjb. Macaulay et al., Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro, J NEURO-ONC, 42(1), 1999, pp. 1-11

Authors: Cano-Gauci, DF Song, HH Yang, HL McKerlie, C Choo, B Shi, W Pullano, R Piscione, TD Grisaru, S Soon, S Sedlackova, L Tanswell, AK Mak, TW Yeger, H Lockwood, GA Rosenblum, ND Filmus, J
Citation: Df. Cano-gauci et al., Glypican-3-deficient mice exhibit developmental overgrowth and some of theabnormalities typical of Simpson-Golabi-Behmel syndrome, J CELL BIOL, 146(1), 1999, pp. 255-264

Authors: Dimitroulakos, J Pienkowska, M Sun, PZ Farooq, S Zielenska, M Squire, JA Yeger, H
Citation: J. Dimitroulakos et al., Identification of a novel zinc finger gene, zf5-3, as a potential mediatorof neuroblastoma differentiation, INT J CANC, 81(6), 1999, pp. 970-978

Authors: Marks, A Sutherland, DR Bailey, D Iglesias, J Law, J Lei, R Yeger, H Banerjee, D Baumal, R
Citation: A. Marks et al., Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours, BR J CANC, 80(3-4), 1999, pp. 569-578

Authors: Dimitroulakos, J Nohynek, D Backway, KL Hedley, DW Yeger, H Freedman, MH Minden, MD Penn, LZ
Citation: J. Dimitroulakos et al., Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach, BLOOD, 93(4), 1999, pp. 1308-1318
Risultati: 1-13 |